ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease

ClinicalTrials.gov ID: NCT05999747

Public ClinicalTrials.gov record NCT05999747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Prospective, Randomized, Open-label Study for Intraoperative Ureter(s) Visualization When Using ASP5354 With Near-infrared Fluorescence (NIR-F) Imaging in Adult Participants Undergoing Minimally Invasive and Open Abdominopelvic Surgeries

Study identification

NCT ID
NCT05999747
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Global Development, Inc.
Industry
Enrollment
95 participants

Conditions and interventions

Interventions

  • pudexacianinium chloride Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 18, 2024
Primary completion
Oct 12, 2025
Completion
Oct 12, 2025
Last update posted
Nov 4, 2025

2024 – 2025

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Cedars Sinai Medical Center Los Angeles California 90048
Hoag Memorial Hospital Presbyterian Newport Beach California 92663
University of South Florida Tampa Florida 33606
Cleveland Clinic Florida Weston Florida 33331
Washington University Center St Louis Missouri 63110
University of Nevada, Las Vegas Las Vegas Nevada 89102
Duke University Hospital Durham North Carolina 27705
Firsthealth of the Carolinas INC Pinehurst North Carolina 28374
Temple University Hospital Philadelphia Pennsylvania 19140
Baylor College of Medicine Houston Texas 77030
Houston Methodist Hospital Houston Texas 77030
Benaroya Research Institute at VA Mason Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05999747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 4, 2025 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05999747 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →